Quoin Pharmaceuticals, Ltd. (QNRX)

Price & Market Data

Price: $4.75

Daily Change: -$0.10 / 2.11%

Daily Range: $4.59 - $5.10

Market Cap: $9,580,154

Daily Volume: 28,882

Performance Metrics

1 Week: -15.30%

1 Month: -18.01%

3 Months: -46.42%

6 Months: -74.37%

1 Year: -41.75%

YTD: -66.02%

About Quoin Pharmaceuticals, Ltd. (QNRX)

Explore Quoin Pharmaceuticals, Ltd. (QNRX)'s performance at a glance. Current price: 4.75, daily change: -$0.10 / 2.11%. Market cap: 9,580,154. Focus on its YTD and 3-month performance.

Company Details

Employees: 4

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.

Selected stocks

USA Oil ETF (USO)

SmartRent, Inc. (SMRT)

Acurx Pharmaceuticals, Inc. (ACXP)

Arq, Inc. (ARQ)

Intercure Ltd. (INCR)